MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic
healthcare company based in Japan (the “Company”), today announced
its major Key Performance Indicators, or KPIs, updated for the
month of November 2024. Data is provided for all salons for which
comparable financial and customer data is available and excludes
certain salons where such information is not available.
Salon Operation BusinessThe
following monthly KPIs provide insight into the business
fundamentals and progress of the Company, updated for the month of
November 2024:
- Total customers served increased to
75,760 in November 2024 from 75,290 in the year-ago period.
- Sales per customer increased to JPY
7,055 in November 2024 from JPY 7,045 in the year-ago period.
- Repeat ratio, which indicates the
percentage of repeat customers, was 77.5% in 2024, the same as
77.5% in the year-ago period.
- Operation ratio was 44.6% in
November 2024, up from 43.9% in the year-ago period.
|
Number of Salons(*1) |
Number of Salons with Data(*2) |
Total Customers Served(*3) |
Sales per Customer(*4) |
Repeat Ratio(*5) |
Operation Ratio(*6) |
November-23 |
313 |
289 |
75,290 |
JPY 7,045 |
77.5% |
43.9% |
December-23 |
314 |
290 |
83,124 |
JPY 7,271 |
77.7% |
46.7% |
January-24 |
311 |
287 |
74,533 |
JPY 7,147 |
76.8% |
44.7% |
February-24 |
311 |
287 |
71,376 |
JPY 7,099 |
77.6% |
44.9% |
March-24 |
312 |
288 |
77,854 |
JPY 7,190 |
77.9% |
45.7% |
April-24 |
308 |
285 |
74,621 |
JPY 7,143 |
75.9% |
43.5% |
May-24 |
307 |
284 |
80,512 |
JPY 6,964 |
74.8% |
44.9% |
June-24 |
308 |
285 |
82,656 |
JPY 7,061 |
75.6% |
47.4% |
July-24 |
309 |
286 |
81,580 |
JPY 7,060 |
75.0% |
46.6% |
August-24 |
307 |
283 |
83,770 |
JPY 7,144 |
75.1% |
47.3% |
September-24 |
308 |
284 |
82,401 |
JPY 7,158 |
75.8% |
48.0% |
October-24 |
307 |
282 |
79,571 |
JPY 6,923 |
76.6% |
45.5% |
November-24 |
308 |
283 |
75,760 |
JPY 7,055 |
77.5% |
44.6% |
|
|
|
|
|
|
|
(*1) Number of Salons: Includes the Company’s
directly-operated salons and franchisees’ salons.(*2) Number of
Salons with Data: The number of salons for which comparable
financial and customer data is available.(*3) Total Customers
Served: The number of customers served at salons for which
comparable financial and customer data is available.(*4) Sales Per
Customer: The ratio of total salon sales to number of treated
customers at all salons for which comparable financial and customer
data is available.(*5) Repeat Ratio: The ratio of repeat customer
visits to total customer visits in the applicable month for all
salons for which comparable financial and customer data is
available.(*6) Operation Ratio: The ratio of therapists’ in-service
time to total therapists’ working hours (including stand-by time)
for the applicable month for all salons for which comparable
financial and customer data is available.
* Repeat ratios shown in the chart above do not
include salons in public bath houses. In November 2024, the repeat
ratios for all salons and salons in public bathhouses only were
77.5% and 56.9%, respectively.
*Since July 2021, the salon operation business has
been managed by Wing Inc., which is a wholly-owned subsidiary of
the Company.
Health Tech Business
(Lav®)The Company offers a
government-specific health guidance program (the “Program”) using
Lav®, an on-demand training application developed by the Company.
The Program is designed to be less burdensome for the users and is
delivered through a completely remote support style using the web
remote interview and chat function of Lav®. This approach helps to
reduce the dropout rate of conventional specific health guidance
programs.
The Program provides support to medical
professionals, such as public health nurses, dietitians, etc., that
assist eligible individuals (age between 40 and 74) who are at risk
of developing lifestyle-related diseases that can be caused by an
unbalanced diet, lack of sleep, lack of exercise, smoking, stress,
and other factors, by reviewing their lifestyle habits through
specific health checkups that focus on metabolic syndrome. The
implementation of specific health checkups and specific health
guidance has become mandatory for medical insurers in Japan,
including national health insurance and employee health insurance
providers, since April 2008.
The Ministry of Health, Labor and Welfare has
set a nationwide target of at least 70% for specific medical
checkup implementation rates and at least 45% for specific health
guidance implementation rates. In fiscal year 2021, however, the
medical checkup implementation rates and specific health guidance
implementation rates were only 56.5% and 24.6%, respectively. As a
result, the market for these services is expected to expand due to
the government’s effort to achieve the set target implementation
rates. According to a survey by the Japan Health Guidance
Association, the utilization of Information and Communication
Technology (ICT) has been increasing, and the adoption rate has
exceeded 50% due to the impact of COVID-19 in recent years.
As of November 2024, the Company has entered
into contracts with 95 corporate insurance associations, and the
cumulative number of users of the Company’s Lav® app has exceeded
8,000 people, bringing the total to 8,515 individuals.
|
Number of New Contracts with Corporate Insurance
Associations(*1) |
Number of New Users(*2) |
Cumulative Number of Contracts with Corporate Insurance
Associations(*3) |
Cumulative Number of Users |
November-23 |
1 |
256 |
73 |
6,262 |
December-23 |
1 |
161 |
74 |
6,423 |
January-24 |
1 |
174 |
75 |
6,597 |
February-24 |
1 |
152 |
76 |
6,749 |
March-24 |
1 |
203 |
76 |
6,952 |
April-24 |
3 |
187 |
79 |
7,139 |
May-24 |
2 |
99 |
81 |
7,238 |
June-24 |
2 |
131 |
83 |
7,369 |
July-24 |
1 |
166 |
84 |
7,535 |
August-24 |
3 |
109 |
87 |
7,644 |
September-24 |
0 |
221 |
87 |
7,865 |
October-24 |
6 |
320 |
93 |
8,185 |
November-24 |
2 |
330 |
95 |
8,515 |
|
|
|
|
|
(*1) Number of new contracts with corporate
insurance associations entered into in the applicable month to
implement specified health guidance program offered by the
Company.(*2) Number of new users that started using specified
health guidance offered by the Company in the applicable month.(*3)
Cumulative number of contracts with corporate insurance
associations excluding the number of terminated contracts.
Forward-Looking
StatementsCertain statements in this press release are
forward-looking statements for purposes of the safe harbor
provisions under the U.S. Private Securities Litigation Reform Act
of 1995. Forward-looking statements may include estimates or
expectations about the Company’s possible or assumed operational
results, financial condition, business strategies and plans, market
opportunities, competitive position, industry environment, and
potential growth opportunities. In some cases, forward-looking
statements can be identified by terms such as “may,” “will,”
“should,” “design,” “target,” “aim,” “hope,” “expect,” “could,”
“intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,”
“predict,” “project,” “potential,” “goal,” or other words that
convey the uncertainty of future events or outcomes. These
statements relate to future events or to the Company’s future
financial performance, and involve known and unknown risks,
uncertainties and other factors that may cause the Company’s actual
results, levels of activity, performance, or achievements to be
different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking
statements. You should not place undue reliance on forward-looking
statements because they involve known and unknown risks,
uncertainties and other factors which are, in some cases, beyond
the Company’s control and which could, and likely will, affect
actual results, levels of activity, performance or achievements.
Any forward-looking statement reflects the Company’s current views
with respect to future events and is subject to these and other
risks, uncertainties and assumptions relating to the Company’s
operations, results of operations, growth strategy and liquidity.
Some of the factors that could cause actual results to differ
materially from those expressed or implied by the forward-looking
statements in this press release include:
- the Company’s ability to achieve
its development goals for its business and execute and evolve its
growth strategies, priorities and initiatives;
- the Company’s ability to sell
certain of its owned salons to investors, and receive management
fees from such sold salons, on acceptable terms;
- changes in Japanese and global
economic conditions and financial markets, including their effects
on the Company’s expansion in Japan and certain overseas
markets;
- the Company’s ability to achieve
and sustain profitability in its Digital Preventative Healthcare
Segment;
- the fluctuation of foreign exchange
rates, which affects the Company’s expenses and liabilities payable
in foreign currencies;
- the Company’s ability to hire and
train a sufficient number of therapists and place them at salons in
need of additional staffing;
- changes in demographic,
unemployment, economic, regulatory or weather conditions affecting
the Tokyo region of Japan, where the Company’s relaxation salon
base is geographically concentrated;
- the Company’s ability to maintain
and enhance the value of its brands and to enforce and maintain its
trademarks and protect its other intellectual property;
- the financial performance of the
Company’s franchisees and the Company’s limited control with
respect to their operations;
- the Company’s ability to raise
additional capital on acceptable terms or at all;
- the Company’s level of indebtedness
and potential restrictions on the Company under the Company’s debt
instruments;
- changes in consumer preferences and
the Company’s competitive environment;
- the Company’s ability to respond to
natural disasters, such as earthquakes and tsunamis, and to global
pandemics, such as COVID-19; and
- the regulatory environment in which
the Company operates.
More information on these risks and other
potential factors that could affect the Company’s business,
reputation, results of operations, financial condition, and stock
price is included in the Company’s filings with the Securities and
Exchange Commission (the “SEC”), including in the “Risk Factors”
and “Operating and Financial Review and Prospects” sections of the
Company’s most recently filed periodic report on Form 20-F and
subsequent filings, which are available on the SEC website at
www.sec.gov. The Company assumes no obligation to update or revise
these forward-looking statements for any reason, or to update the
reasons actual results could differ from those anticipated in these
forward-looking statements, even if new information becomes
available in the future.
About MEDIROM Healthcare Technologies
Inc.MEDIROM, a holistic healthcare company, operates 308
(as of November 30, 2024) relaxation salons across Japan, Re.Ra.Ku®
being its leading brand, and provides healthcare services. In 2015,
MEDIROM entered the health tech business and launched new
healthcare programs using an on-demand training app called “Lav®”,
which is developed by the Company. MEDIROM also entered the device
business in 2020 and has developed a smart tracker “MOTHER
Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring
system for corporate clients, and has received orders from a broad
range of industries, including nursing care, transportation,
construction, and manufacturing, among others. MEDIROM hopes that
its diverse health-related product and service offerings will help
it collect and manage healthcare data from users and customers and
enable it to become a leader in big data in the healthcare
industry. For more information, visit https://medirom.co.jp/en.
ContactsInvestor Relations
Teamir@medirom.co.jp
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/044097ba-afae-4c7e-873a-d6c864729cce
https://www.globenewswire.com/NewsRoom/AttachmentNg/095a807a-8dbc-43a6-9a11-0a2a1417d3db
https://www.globenewswire.com/NewsRoom/AttachmentNg/a31937c9-e59c-4cff-9c46-0e75e4440dd2
https://www.globenewswire.com/NewsRoom/AttachmentNg/f2fcdb5d-8393-46d1-9f3d-73d7a4e2ecb4
https://www.globenewswire.com/NewsRoom/AttachmentNg/e6ed0bcb-54f5-419b-b54d-d3f0086f4bdc
https://www.globenewswire.com/NewsRoom/AttachmentNg/ec917127-1447-4db9-bf54-c489f757898e
https://www.globenewswire.com/NewsRoom/AttachmentNg/09ed0042-eb22-4eb2-b449-6ad4bb0b1298
MEDIROM Healthcare Techn... (NASDAQ:MRM)
過去 株価チャート
から 11 2024 まで 12 2024
MEDIROM Healthcare Techn... (NASDAQ:MRM)
過去 株価チャート
から 12 2023 まで 12 2024